Quantcast

Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.

Research paper by Serge S Gauthier

Indexed on: 03 Feb '09Published on: 03 Feb '09Published in: Frontiers of neurology and neuroscience



Abstract

The pharmacotherapy of Parkinson disease dementia and Lewy body dementia with cholinesterase inhibitors and selected psychotropic drugs is relatively new. Review of literature supplemented by expert opinion. Cholinesterase inhibitors can be used by primary care practitioners and specialists, with often clinically meaningful results. Primary care practitioners play an essential role in the diagnosis and management of patients with these conditions.